Che‐1 is targeted by c‐Myc to sustain proliferation in pre‐B‐cell acute lymphoblastic leukemia

Despite progress in treating B‐cell precursor acute lymphoblastic leukemia (BCP‐ALL), disease recurrence remains the main cause of treatment failure. New strategies to improve therapeutic outcomes are needed, particularly in high‐risk relapsed patients. Che‐1/AATF (Che‐1) is an RNA polymerase II‐bin...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:EMBO Rep
Auteurs principaux: Folgiero, Valentina, Sorino, Cristina, Pallocca, Matteo, De Nicola, Francesca, Goeman, Frauke, Bertaina, Valentina, Strocchio, Luisa, Romania, Paolo, Pitisci, Angela, Iezzi, Simona, Catena, Valeria, Bruno, Tiziana, Strimpakos, Georgios, Passananti, Claudio, Mattei, Elisabetta, Blandino, Giovanni, Locatelli, Franco, Fanciulli, Maurizio
Format: Artigo
Langue:Inglês
Publié: John Wiley and Sons Inc. 2018
Sujets:
Articles
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5835840/
https://ncbi.nlm.nih.gov/pubmed/29367285
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.15252/embr.201744871
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires